000 01286 a2200349 4500
005 20250515004501.0
264 0 _c20060209
008 200602s 0 0 eng d
022 _a1528-4050
024 7 _a10.1097/01.all.0000191236.35879.f2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRolland, Jennifer M
245 0 0 _aAdvances in development of hypoallergenic latex immunotherapy.
_h[electronic resource]
260 _bCurrent opinion in allergy and clinical immunology
_cDec 2005
300 _a544-51 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAllergens
_xchemistry
650 0 4 _aDesensitization, Immunologic
650 0 4 _aEpitopes, B-Lymphocyte
650 0 4 _aEpitopes, T-Lymphocyte
650 0 4 _aHevea
_xadverse effects
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aLatex
_xadverse effects
650 0 4 _aLatex Hypersensitivity
_xtherapy
650 0 4 _aMutation
650 0 4 _aRecombinant Proteins
700 1 _aDrew, Alexander C
700 1 _aO'Hehir, Robyn E
773 0 _tCurrent opinion in allergy and clinical immunology
_gvol. 5
_gno. 6
_gp. 544-51
856 4 0 _uhttps://doi.org/10.1097/01.all.0000191236.35879.f2
_zAvailable from publisher's website
999 _c15890719
_d15890719